SEC Form 4 · accession 0001225208-17-005153

BOSTON SCIENTIFIC CORP · BSX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — SVP&Pres, Endoscopy

Period of report

Feb 28, 2017

Accepted (ET)

Mar 1, 2017 · 8:55 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000885725

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1,F2	Feb 28, 2017	M	3,383	$0.00	A	15,201	D
Common Stock^F2	Feb 28, 2017	F	1,592	$24.55	D	13,609	D
Common Stock^F3	holding	—	—		—	2,565	I	By 401(k)

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Deferred Stock Units^F1,F4	—	Feb 28, 2017	A	7,637	A	—	Feb 28, 2022	Common Stock	7,637	7,637	D
Deferred Stock Units^F1,F5	—	Feb 28, 2017	M	3,383	D	Feb 28, 2018	Feb 28, 2018	Common Stock	3,383	3,383	D
Stock Option (Right to Buy)^F6	$24.55	Feb 28, 2017	A	24,703	A	—	Feb 28, 2027	Common Stock	24,703	24,703	D

F1Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
F3Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.
F4Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.
F5Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant.
F6Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.